C5 (UK) will be holding its Biotech Patenting conference on September 23-24, 2008 in London, England. The conference will allow attendees to:
• Analyze the practical impact of recent changes at the UK-IPO, EPO, and USPTO;
• Increase knowledge of developments in follow-on biologics and antibody technologies in the patent area;
• Manage the challenges posed by the conflicting legal approaches to gene patenting;
• Establish a successful global patent strategy and successfully protect biotech patents in China and India;
• Get the latest information on second medical use claims; and
• Tackle inventorship and patent entitlement disputes.
In particular, C5 faculty will offer presentations on the following topics:
• Critical update on legislative and policy developments at the UK-IPO and EPO;
• EPO insight: An examiner’s perspective on biotech patent applications;
• Review of recent EPO and EU National Court biotech decisions;
• Impact of the EPC 2000 on medical use claims;
• Analysis of the latest decisions of the U.S. courts and their implications;
• Implications and status of the patent reform act;
• Obviousness determinations after KSR v. Teleflex;
• How to successfully obtain and enforce your biotech patents in China and India;
• Keynote presentation: Judicial address from Federal Circuit Judge Randall Rader;
• Developing your patent strategy to develop competitive advantage, obtain maximum revenue and extend patent lifecycles;
• Unravelling the legal conflict in gene patenting in Europe;
• Comparison of the U.S. and European legal issues surrounding biosimilars: Legislation, case law, and approvals to date;
• Case study on bringing and defending inventorship and patent entitlement actions; and
• Managing your biotech patent litigation: In-house and outside counsel perspectives.
Two additional pre-conference workshops will be offered on September 22, 2008. The first pre-conference workshop, entitled "Advanced Practical Workshop on Successfully Evaluating Freedom to Operate" and "Successfully Evaluating Freedom to Operate," will held from 8:30 am to 12:00 pm, and will cover the preparation and conduct of FTO searches, including how to analyze FTO search results and communicate them for the purposes of patent procurement and company reporting. This workshop will use a real-life FTO case study to highlight key strategic points, including the design of the FTO search and drafting of the FTO report. The second pre-conference workshop, entitled "How to Conduct Effective IP Due Diligence," will be held from 1:00 pm to 4:30 pm, and will provide step-by-step guidance on how to conduct thorough due diligence and ensure that costly mistakes that erode IP value are avoided. In addition to providing information on key legal and business issues impacting IP due diligence, this workshop will provide insights on the essential components of a due diligence review, spotting IP red flags and managing the reporting process.
The agenda for the Biotech Patenting conference can be found here. A complete brochure for this conference, including an agenda, list of speakers, and registration form can be downloaded here.
The registration fee for the conference is £1878.83 ($3,739.78), for the conference plus one workshop £2582.65 ($5,140.73), and for the conference plus both workshops £3286.48 ($6,541.69); attendees can also register for just one workshop for £703.83 ($1,400.96). For those registering on or before August 26, 2008, the registration fee for the conference is £1643.83 ($3,272.02), for the conference plus one workshop £2347.65 ($4,672.96), for the conference plus both workshops £3051.48 ($6,073.93), and for just one workshop £703.83 ($1,400.96). Those interested in registering for the conference can do so here, by calling +44 (0) 20 7878 6888, by faxing a registration form to +44 (0) 20 7878 6896, or by e-mailing [email protected].
Comments